Citations (17)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Zi-Shan Lin, Xiao-Juan Yu, Xu Zhang, Su-Xia Wang, Xi-Nan Cen, Fu-De Zhou & Ming-Hui Zhao. (2021) Monoclonal Immunoglobulin-Associated Renal Lesions in Patients with Newly Diagnosed Multiple Myeloma: A Report from a Single Center. Cancer Management and Research 13, pages 3879-3888.
Read now
Read now
Hong-Mei Zhang, Xi-Yang Liu, Yu-Zhang Liu, Li-Na Liu, Quan-De Lin, Yong-Ping Song & Bai-Jun Fang. (2019) Analysis of the efficacy and safety of bortezomib for treating newly diagnosed multiple myeloma through different administration methods. Cancer Management and Research 11, pages 8295-8302.
Read now
Read now
Thomas A. Guerrero-Garcia, Sara Gandolfi, Jacob P. Laubach, Teru Hideshima, Dharminder Chauhan, Constantine Mitsiades, Kenneth C. Anderson & Paul G. Richardson. (2018) The power of proteasome inhibition in multiple myeloma. Expert Review of Proteomics 15:12, pages 1033-1052.
Read now
Read now
Jean-Samuel Boudreault, Cyrille Touzeau & Philippe Moreau. (2017) Triplet combinations in relapsed/refractory myeloma: update on recent phase 3 trials. Expert Review of Hematology 10:3, pages 207-215.
Read now
Read now
Articles from other publishers (13)
Laurent Garderet, Hafida Ouldjeriouat, Mohamed‐Amine Bekadja, Elisabeth Daguenet, Noemie Bigot, Laure Vincent, Damien Roos‐Weil, Marguerite Vignon, Souhila Ikhlef, Julie Abraham, Martine Escoffre‐Barbe, Bruno Lioure, Redhouane Ahmed Nacer, Ingrid Lafon, Clara Mariette, Lionel Karlin, Pierre Morel, Lila Gilis, Emanuelle Le Ray, Anaïse Blouet, Stéphanie Nguyen Quoc, Jean Jacques Boffa, Pierre Ronco, Jerome Lambert & Jérôme Cornillon. (2023) Low non‐relapse mortality and good haematological and renal responses after autologous haematopoietic stem cell transplantation in multiple myeloma patients with renal insufficiency at transplant: A prospective Société Francophone de Greffe de Moelle‐Thérapie Cellulaire observational study. British Journal of Haematology.
Crossref
Crossref
Bruno Almeida Costa, Tarek H. Mouhieddine & Joshua Richter. (2022) What’s Old is New: The Past, Present and Future Role of Thalidomide in the Modern-Day Management of Multiple Myeloma. Targeted Oncology 17:4, pages 383-405.
Crossref
Crossref
Xuejiao Yin, Fengjuan Fan, Bo Zhang, Yu Hu & Chunyan Sun. (2022) Cardiovascular-specific mortality among multiple myeloma patients: a population-based study. Therapeutic Advances in Hematology 13, pages 204062072210867.
Crossref
Crossref
Rupa Narayan, Derek Galligan, Ann A. Lazar, Sarah Kim, Richard Fong, Marisela Tan, Mimi Lo, Shagun Arora, Nina Shah, Sandy W. Wong, Thomas Martin & Jeffrey Wolf. (2020) Modified Hyper-CVAD With Proteasome Inhibition for Multiple Myeloma: A Single-Center Retrospective Analysis. Clinical Lymphoma Myeloma and Leukemia 20:12, pages e961-e985.
Crossref
Crossref
Evangelos Terpos, Ioannis Ntanasis-Stathopoulos, Gerasimos-Petros Papassotiriou, Efstathios Kastritis, Alexandra Margeli, Nikolaos Kanellias, Evangelos Eleutherakis-Papaiakovou, Magdalini Migkou, Despina Fotiou, Maria Roussou, Maria Gavriatopoulou, Panagiotis Malandrakis, Erasmia Psimenou, Ioannis Papassotiriou & Meletios A. Dimopoulos. (2020) Circulating Soluble Urokinase-Type Plasminogen Activator Receptor Levels Reflect Renal Function in Newly Diagnosed Patients with Multiple Myeloma Treated with Bortezomib-Based Induction. Journal of Clinical Medicine 9:10, pages 3201.
Crossref
Crossref
S. V. Semochkin, E. I. Zhelnova, E. N. Misyurina, D. S. Maryin, A. I. Ushakova, E. A. Karimova, E. A. Baryakh, T. N. Tolstykh, E. S. Mavrina, E. V. Yurova, A. V. Cherkasova, E. Yu. Grishina, D. E. Gagloeva, K. V. Yatskov, O. N. Kotenko & M. A. Lysenko. (2019) CLINICAL IMPORTANCE OF RENAL RECOVER ON OUTCOMES OF NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS WITH SEVERE AND DIALYSIS-DEPENDENT KIDNEY FAILURE. Russian journal of hematology and transfusiology 64:3, pages 283-296.
Crossref
Crossref
Mohamad Mohty, Michele Cavo, Leah Fink, Sebastian Gonzalez‐McQuire, Henri Leleu, Maria‐Victoria Mateos, Marc S. Raab, Paul Schoen & Kwee Yong. (2019) Understanding mortality in multiple myeloma: Findings of a European retrospective chart review. European Journal of Haematology 103:2, pages 107-115.
Crossref
Crossref
Crystal Antoine-Pepeljugoski & Marc Justin Braunstein. (2019) Management of Newly Diagnosed Elderly Multiple Myeloma Patients. Current Oncology Reports 21:7.
Crossref
Crossref
Khalid Ahmed Al-Anazi. 2019. Update on Multiple Myeloma. Update on Multiple Myeloma.
Sergei Vyacheslavovich Semochkin, G.N. Salogub, S.S. Bessmeltsev & K.D. Kaplanov. (2019) Practical Aspects of the Use of Carfilzomib in Multiple Myeloma. Clinical oncohematology 12:1, pages 21-31.
Crossref
Crossref
Kevin Brigle, Amy Pierre, Elizabeth Finley-Oliver, Beth Faiman, Joseph Tariman, Teresa Miceli & and Board
. (2017) Myelosuppression, Bone Disease, and Acute Renal Failure: Evidence-Based Recommendations for Oncologic Emergencies. Clinical Journal of Oncology Nursing 21:5, pages 60-76.
Crossref
Crossref
Beth Faiman, Deborah Doss, Kathleen Colson, Patricia Mangan, Tracy King, Joseph Tariman & and Board
. (2017) Renal, GI, and Peripheral Nerves: Evidence-Based Recommendations for the Management of Symptoms and Care for Patients With Multiple Myeloma. Clinical Journal of Oncology Nursing 21:5, pages 19-36.
Crossref
Crossref
Fran?ois Vincent, Sondes Yaacoubi, Abdelaziz Bouguerba, Soufia Ayed & Caroline Bornstain. (2017) Cardiopulmonary resuscitation in cancer patients: is there a problem?. Supportive Care in Cancer 25:8, pages 2371-2372.
Crossref
Crossref